Kevin E. Glinton, MD, PhD
As a clinician and researcher, my aim is to provide the most timely and precise diagnosis for patients. I enjoy treating children with a variety of genetic disorders but have a particular interest in the diagnosis and treatment of children with inborn errors of metabolism.
Alaimo, J.T., Glinton, K.E., Liu, N., Xiao, J., Yang, Y., Sutton, V.R. and Elsea, S.H., 2020. Integrated analysis of metabolomic profiling and exome data supplements sequence variant interpretation, classification, and diagnosis. Genetics in Medicine pp.1-7.
Glinton, K.E., Levy, H.L., Kennedy, A.D., Pappan, K.L. and Elsea, S.H., 2019. Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in UROC1. Molecular Genetics and Metabolism Reports 18, pp.14-18.
Glinton, K.E., Benke, P.J., Lines, M.A., Geraghty, M.T., Chakraborty, P., Al-Dirbashi, O.Y., Jiang, Y., Kennedy, A.D., Grotewiel, M.S., Sutton, V.R. and Elsea, S.H., 2018. Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling. Molecular Genetics and Metabolism 123(3), pp.309-316.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.